Ambry Genetics, Looking to Entice Pharma, Rolls out CHO Cell Expression Array | GenomeWeb

This story has been updated to include additional comments from Ambry Genetics and Sigma-Aldrich.

By Justin Petrone

Ambry Genetics recently expanded its menu of custom-designed microarrays by launching its CHO Cell Expression Array. The company said it designed the new array to target pharmaceutical companies that produce recombinant proteins in Chinese hamster ovary, or CHO, cells.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.